Predictive Oncology Inc - Company Profile

Powered by

All the data and insights you need on Predictive Oncology Inc in one report.

$ $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date Predictive Oncology Inc Strategy Report

  • Understand Predictive Oncology Inc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Predictive Oncology Inc: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Predictive Oncology Inc (Predictive Oncology) develops personalized cancer therapies by using artificial intelligence. It processes tumor-specific 3D cell culture models to improve patient outcomes in cancer treatment. The company provides oncology solutions through zPREDICTA, Helomics, Skyline and Soluble. Predictive Oncology offers the STREAMWAY system that removes blood, irrigation fluid and other potentially infectious fluids found in the healthcare environment. Its Helomics division provides clinical testing and contract research services to improve the effectiveness of cancer therapy using a multi-omic tumor profiling platform. The company collaborates with pharmaceutical, academic organizations, biotech and diagnostic industries to develop new personalized drugs and diagnostics. Predictive Oncology is headquartered in Eagan, Minnesota, the US.

 Gain a 360-degree view of Predictive Oncology Inc and make more informed decisions for your business Gain a 360-degree view of Predictive Oncology Inc and make more informed decisions for your business Find out more
Headquarters United States of America
Address 91 43rd Street, Suite 110, Pittsburgh, Pennsylvania, 15201
Website predictive-oncology.com
Telephone 1 412 4321500
No of Employees 34
Industry Pharmaceuticals and Healthcare
Ticker Symbol & Exchange POAI (NASD)
Revenue (2022) $1.8M 18.2% (2022 vs 2021)
EPS XYZ
Net Income (2022) XYZ 45.7% (2022 vs 2021)
Market Cap* $6.9M
Net Profit Margin (2022) XYZ 54.1% (2022 vs 2021)
* As of and is in US$
View Predictive Oncology Inc financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Predictive Oncology Inc premium industry data and analytics

3

Clinical Trials

Determine Predictive Oncology Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

2

Pipeline Drugs

Identify which of Predictive Oncology Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

Products and Services

Products Services Brands
Multi-omic Tumor Profiling Platforms Clinical Testing Helomics
The STREAMWAY Systems Contract Research Service zPREDICTA
Soluble
XYZ
XYZ
XYZ
Understand Predictive Oncology Inc portfolio and identify potential areas for collaboration Understand Predictive Oncology Inc portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2023 Contracts/Agreements In March, the company entered into Partnership with Cancer Research UK to accelerate the progress of oncology drug development through the utilization of Predictive Oncology's PEDAL platform.
2023 Contracts/Agreements In March, the company partnered with Integra Therapeutics to use gene editing for future cancer therapies.
2023 New Products/Services In February, the company announced the launch of ACE (Accelerating Compound Exploration).
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters Predictive Oncology Inc Harpoon Therapeutics Inc Cogent Biosciences Inc Curemetrix Inc Oncora Medical Inc
Headquarters United States of America United States of America United States of America United States of America United States of America
City Pittsburgh South San Francisco Waltham La Jolla Philadelphia
State/Province Pennsylvania California Massachusetts California Pennsylvania
No. of Employees 34 53 164 - -
Entity Type Public Private Public Private Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Raymond F. Vennare Chairman; Chief Executive Officer Executive Board 2022 70
Larry DeLucas, Ph.D. Senior Vice President - Biologics - Predictive Oncology Senior Management - -
Josh Blacher Chief Financial Officer - Interim Senior Management 2023 -
Theresa Ferguson Senior Director - Marketing Senior Management 2023 -
Arlette H. Uihlein, MD, FCAP, FASCP Director - Medical; Senior Vice President - Translational Medicine and Drug Discovery Senior Management - -
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Predictive Oncology Inc key executives to enhance your sales strategy Gain insight into Predictive Oncology Inc key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer